CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats

por Zhao, Li, Liu, Tao, Dou, Zhan-jun, Wang, Mei-ting, Hu, Zi-xuan, Wang, Bei
Publicado 2021

Intestinal microbiomics and liver metabolomics insights into the preventive effects of chromium (III)-enriched yeast on hyperlipidemia and hyperglycemia induced by high-fat and hig...

por Wang, Mei-Ting, Guo, Wei-Ling, Yang, Zi-Yi, Chen, Feng, Lin, Tian-Tian, Li, Wen-Long, Lv, Xu-Cong, Rao, Ping-Fan, Ai, Lian-Zhong, Ni, Li
Publicado 2022

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats

por Dou, Zhan-jun, Gao, Xiao-Ling, Jia, Yan-li, Chen, Jie, Yang, Jiao-Jiao, Chen, Yan, Wu, Shu-jie, Liu, Tao, Wang, Mei-ting, Yang, Chong, Zhang, Na, Wang, Bei
Publicado 2020